Selected Sources and Further Reading Mark Gordon interview: hormones, biomarkers, neuroinflammation and peptides
In a previous piece covering semaglutide and other GLP-1 medication, we discussed some of the ways that employers are adapting in order to offer these drug treatments to employees without exposing the health plan to out-of-control costs, including implementing lifetime caps, minimum BMI caps, and limiting access to cheaper GLP-1 options: Lifetime Cap : Some employers are limiting their exposure to excessive GLP-1 weight loss expenses by setting a lifetime cap on the amount of funds available to covered employees
I always like carnitine and this is good if nothing groundbreaking in terms of what it does :) L-Carnitine Ernie - 07 January 2020 Life extension may some really top end products, and whilst you might think they are re-branding regular carnitine with a big price, I used these during one of my cuts, and they were noticeably better than the brand I had used before
In an interview, Marong said patients ask about the new drugs "all the time," but he doesn't always write those patients a prescription, particularly if they are below a BMI of 30
That translates to 200 mg to 1,200 mg of tirzepatide per day, depending on the target dose